Jia M. Loo
Singapore, Singapore
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Modeling oxaliplatin resistance in colorectal cancer reveals a SERPINE1-based gene signature (RESIST-M) and therapeutic strategies for pro-metastatic CMS4 subtype.
Journal: Cell death & disease
Published: January 08, 2025
A comparative study of tumour-on-chip models with patient-derived xenografts for predicting chemotherapy efficacy in colorectal cancer patients.
Journal: Frontiers in bioengineering and biotechnology
Published: May 25, 2022
Therapeutic targeting of SLC6A8 creatine transporter suppresses colon cancer progression and modulates human creatine levels.
Journal: Science advances
Published: October 06, 2021
Functional genetic screen identifies ITPR3/calcium/RELB axis as a driver of colorectal cancer metastatic liver colonization.
Journal: Developmental cell
Published: September 12, 2021
Single-cell and bulk transcriptome sequencing identifies two epithelial tumor cell states and refines the consensus molecular classification of colorectal cancer.
Journal: Nature genetics
Published: July 27, 2021
DUSP16 promotes cancer chemoresistance through regulation of mitochondria-mediated cell death.
Journal: Nature communications
Published: August 29, 2019
Dual-faced SH3BGRL: oncogenic in mice, tumor suppressive in humans.
Journal: Oncogene
Published: July 13, 2015
PKLR promotes colorectal cancer liver colonization through induction of glutathione synthesis.
Journal: The Journal of clinical investigation
Published: July 10, 2015
Extracellular metabolic energetics can promote cancer progression.
Journal: Cell
Published: April 03, 2014
Showing 1-11 of 11
Last Updated: 09/26/2026